TITLE

NYGGF4 ( PID1) effects on insulin resistance are reversed by metformin in 3T3-L1 adipocytes

AUTHOR(S)
Qiu, Jie; Wang, Yu-mei; Shi, Chun-mei; Yue, Hong-ni; Qin, Zhen-Ying; Zhu, Guan-zhong; Cao, Xin-guo; Ji, Chen-bo; Cui, Yan; Guo, Xi-rong
PUB. DATE
December 2012
SOURCE
Journal of Bioenergetics & Biomembranes;Dec2012, Vol. 44 Issue 6, p665
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
NYGGF4 (also called PID1) is a recently discovered gene that is involved in obesity-related insulin resistance (IR). We aimed in the present study to further elucidate the effects of NYGGF4 on IR and the underlying mechanisms through using metformin treatment in 3T3-L1 adipocytes. Our data showed that the metformin pretreatment strikingly enhanced insulin-stimulated glucose uptake through increasing GLUT4 translocation to the PM in NYGGF4 overexpression adipocytes. NYGGF4 overexpression resulted in significant inhibition of tyrosine phosphorylation of IRS-1 and serine phosphorylation of Akt, whereas incubation with metformin strongly activated IRS-1 and Akt phosphorylation in NYGGF4 overexpression adipocytes. The reactive oxygen species (ROS) levels in NYGGF4 overexpression adipocytes were strikingly enhanced, which could be decreased by the metformin pretreatment. Our data also showed that metformin increased the expressions of PGC1-α, NRF-1, and TFAM, which were reduced in the NYGGF4 overexpression adipocytes. These results suggest that NYGGF4 plays a role in IR and its effects on IR could be reversed by metformin through activating IRS-1/PI3K/Akt and AMPK-PGC1-α pathways.
ACCESSION #
83586521

 

Related Articles

  • Metformin Inhibits Expression and Secretion of PEDF in Adipocyte and Hepatocyte via Promoting AMPK Phosphorylation. Shumin Yang; Qiong Lv; Ting Luo; Lulu Liu; Rufei Gao; Shumei Chen; Peng Ye; Qingfeng Cheng; Qifu Li // Mediators of Inflammation;2013, Vol. 2013, p1 

    Objective. Pigment epithelium-derived factor (PEDF) plays an important role in obesity-induced insulin resistance (IR). The study aims to investigate the effect of metformin, a widely used agent to improve IR, on PEDF production both in vivo and in vitro. Methods. SD rats were divided into...

  • Autocrine Action of Adiponectin on Human Fat Cells Prevents the Release of Insulin Resistance-Inducing Factors. Dietze-Schroeder, Daniela; Sell, Henrike; Uhlig, Mathias; Koenen, Marlis; Eckel, Jürgen // Diabetes;Jul2005, Vol. 54 Issue 7, p2003 

    The adipocyte hormone adiponectin is negatively correlated with obesity and insulin resistance and may exert an important antidiabetes function. In this study, primary human skeletal muscle cells were cocultured with human fat cells or incubated with adipocyte-conditioned medium in the presence...

  • Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes. Zhang, Chun-Mei; Zeng, Xue-Qi; Zhang, Rong; Ji, Chen-Bo; Tong, Mei-Ling; Chi, Xia; Li, Xi-Ling; Dai, Jia-Zheng; Zhang, Min; Cui, Yan; Guo, Xi-Rong // Journal of Bioenergetics & Biomembranes;Oct2010, Vol. 42 Issue 5, p433 

    NYGGF4 is a recently discovered gene that is involved in obesity-associated insulin resistance. It has been suggested that mitochondrial dysfunction might be responsible for the development of insulin resistance induced by NYGGF4 overexpression. In the present study, we aimed to define the...

  • Blame ROS. Kritikou, Ekat // Nature Reviews Molecular Cell Biology;Jun2006, Vol. 7 Issue 6, p384 

    Discusses research being done on the role of reactive oxygen species in multiple forms of insulin resistance. Reference to a study by N. Houstis et al published in a 2006 issue of "Nature"; Occurrence of insulin resistance in diseases including type-2 diabetes, obesity, sepsis and metabolic...

  • Reduced Expression of p70S6 Kinase Rescues 3T3-L1 Adipocytes from Constitutively Active Akt Induced Insulin Resistance due to Serine Phosphorylation of IRS-1. Adochio, Rebecca L.; Hedlund, Reed A.; Leitner, J. W.; Draznin, Boris // Diabetes;Jun2007 Supplement 1, Vol. 56, pA332 

    Phosphorylation of IRS-1 on serine residues 307 and 636 has been recognized as a feedback mechanism responsible for insulin resistance and diminution of insulin action. Activation of p70S6 kinase by nutrients, Akt, and insulin has been identified as a pathway leading to phosphorylation of IRS-1...

  • Obesity: New life for antidiabetic drugs. Houtkooper, Riekelt H.; Auwerx, Johan // Nature;7/22/2010, Vol. 466 Issue 7305, p443 

    The article offers information on the study which examines the role of phosphorylation of protein PPARB3; on insulin resistance and obesity. It states that PPARB3; activators can be used as insulin sensitizers. It mentions that activation of the enzyme cyclin-dependent kinase 5 (CDK5)...

  • Protein links obesity to diabetes.  // GP: General Practitioner;7/22/2005, p4 

    The article reports that a protein produced by visceral fat that causes insulin resistance could account for the link between obesity and type-2 diabetes. Researchers looked at differences in the gene expression of mice with fat cells that did and did not respond properly to insulin to see how...

  • Metformin Improves Insulin Signaling in Obese Rats via Reduced IKKβ Action in a Fiber-Type Specific Manner. Benjamin T. Bikman; Donghai Zheng; Kane, Daniel A.; Anderson, Ethan J.; Woodlief, Tracey L.; Price, Jesse W.; Dohm, G. Lynis; Neufer, P. Darrell; Cortright, Ronald N. // Journal of Obesity;2010, Vol. 2010, p1 

    Metformin is a widely used insulin-sensitizing drug, though its mechanisms are not fully understood. Metformin has been shown to activate AMPK in skeletal muscle; however, its effects on the inhibitor of κB kinaseß (IKKß) in this same tissue are unknown. The aim of this study was to (1)...

  • Overexpression of PGC-1β improves insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes. Chun-Lin Gao; Guang-Ling Liu; Shi Liu; Xiao-Hui Chen; Chen-Bo Ji; Chun-Mei Zhang; Zheng-Kun Xia; Xi-rong Guo // Molecular & Cellular Biochemistry;Jul2011, Vol. 353 Issue 1/2, p215 

    The co-transcription factor peroxisome proliferator-activated receptor γ coactivator-1β (PGC-1β) was first identified in 2002. Although the function of PGC-1β in white adipose tissue (WAT) is largely unknown, it has been studied extensively in the liver, cardiac muscle, and skeletal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics